Related Experiment Video
Updated: May 31, 2026

Real-time Analyses of Retinol Transport by the Membrane Receptor of Plasma Retinol Binding Protein
Published on: January 28, 2013
The positive correlation between cord serum retinol-binding protein 4 concentrations and fetal growth
Te-Fu Chan1, Yung-Chieh Tsai, Chen-Hsuan Wu
1Department of Obstetrics and Gynecology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung, Taiwan, ROC.
Insights
Cord serum retinol-binding protein 4 (RBP4) levels were higher in larger fetuses. Higher RBP4 concentrations correlate with fetal birth weight, suggesting RBP4 may regulate fetal growth.
Area of Science:
- Endocrinology
- Metabolic Research
- Perinatal Medicine
Background:
- Retinol-binding protein 4 (RBP4) is linked to insulin resistance and fatty acid metabolism.
- The role of RBP4 in fetal growth remains largely unexplored.
- RBP4 may serve as a fetal growth marker independent of insulin levels.
Purpose of the Study:
- To investigate the association between cord serum RBP4 and fetal growth.
- To determine if cord serum RBP4 can predict fetal birth weight.
Main Methods:
- A case-control study involving 42 women and their fetuses.
- Fetuses were categorized into top (>75th percentile) and bottom (<25th percentile) quartiles of birth weight for gestational age.
- Serum RBP4 and insulin levels were measured in cord blood.
Main Results:
- Cord serum RBP4 and insulin concentrations were significantly higher in the top quartile birth weight group compared to the bottom quartile group.
- Cord serum RBP4 and insulin levels, along with gestational age, showed a significant positive correlation with fetal birth weight.
- RBP4 levels were 14.3 ± 3.7 ng/ml in the high birth weight group versus 11.3 ± 2.6 ng/ml in the low birth weight group.
Conclusions:
- Cord serum RBP4 concentrations are elevated in fetuses with higher birth weights.
- RBP4 levels are significantly correlated with fetal birth weight, suggesting a potential regulatory role in fetal development.
- Cord serum RBP4 may serve as a valuable biomarker for assessing fetal growth and potential growth abnormalities.
Background/Aims:
Retinol-binding protein 4 (RBP4) has been shown to be associated with insulin resistance and fatty acid metabolism. We hypothesize that RBP4 might play a role in fetal growth and that cord serum RBP4 may act as a marker of fetal growth, independent of fetal insulin levels.
Methods:
Twenty-one women having fetuses in the top quartile (>75th percentile) of birth weights for gestational age were enrolled into the trial, along with 21 women having fetuses in the bottom quartile (<25th percentile) of birth weights for gestational age. Serum RBP4 and insulin levels were analyzed.
Results:
Cord serum RBP4 and insulin concentrations were significantly higher in the top quartile group (14.3 ± 3.7 ng/ml, 3.8 ± 5.2 μIU/ml) than in the bottom quartile group (11.3 ± 2.6 ng/ml, 0.9 ± 1.4 μIU/ml; p = 0.004, p = 0.017). Cord serum RBP4 and insulin as well as gestational age (r = 0.744, r(2) = 0.553, p < 0.001) were significantly correlated with fetal birth weights.
Conclusion:
Cord serum RBP4 concentrations were higher in subjects with top quartile fetuses than in those with bottom quartile fetuses. Cord serum RBP4 concentrations were significantly correlated with fetal birth weight. These findings may indicate that cord serum RBP4 plays a regulatory role in fetal growth.
Related Concept Videos
Regression Toward the Mean
Correlations
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...